-
1
-
-
79958043675
-
-
National Cancer Institute, Bethesda, Md, USA, based on November 2013 SEER data submission, posted to the SEER web site, April 2014
-
N. Howlader, A. Noone, M. Krapcho et al., Cronin K SEER Cancer Statistics Review, 1975-2011, National Cancer Institute, Bethesda, Md, USA, 2013, based on November 2013 SEER data submission, posted to the SEER web site, April 2014, http://seer.cancer.gov/csr/1975-2011/.
-
(2013)
SEER Cancer Statistics Review, 1975-2011
-
-
Howlader, N.1
Noone, A.2
Krapcho, M.3
Cronin, K.4
-
2
-
-
84869077150
-
American Thyroid Association guidelines for management of patients with anaplastic thyroid cancer
-
R. C. Smallridge, K. B. Ain, S. L. Asa et al., "American Thyroid Association guidelines for management of patients with anaplastic thyroid cancer," Thyroid, vol. 22, no. 12, pp. 1104-1139, 2012.
-
(2012)
Thyroid
, vol.22
, Issue.12
, pp. 1104-1139
-
-
Smallridge, R.C.1
Ain, K.B.2
Asa, S.L.3
-
3
-
-
84879076365
-
Anaplastic thyroid cancer
-
J. P. O'Neill and A. R. Shaha, "Anaplastic thyroid cancer," Oral Oncology, vol. 49, no. 7, pp. 702-706, 2013.
-
(2013)
Oral Oncology
, vol.49
, Issue.7
, pp. 702-706
-
-
O'Neill, J.P.1
Shaha, A.R.2
-
4
-
-
33745199172
-
Poorly differentiated and anaplastic thyroid cancer
-
K. N. Patel and A. R. Shaha, "Poorly differentiated and anaplastic thyroid cancer," Cancer Control, vol. 13, no. 2, pp. 119-128, 2006.
-
(2006)
Cancer Control
, vol.13
, Issue.2
, pp. 119-128
-
-
Patel, K.N.1
Shaha, A.R.2
-
5
-
-
0027215123
-
Gene p53 mutations are restricted to poorly differentiated and undifferentiated carcinomas of the thyroid gland
-
R. Donghi, A. Longoni, S. Pilotti, P. Michieli, G. Della Porta, and M. A. Pierotti, "Gene p53 mutations are restricted to poorly differentiated and undifferentiated carcinomas of the thyroid gland," Journal of Clinical Investigation, vol. 91, no. 4, pp. 1753-1760, 1993.
-
(1993)
Journal of Clinical Investigation
, vol.91
, Issue.4
, pp. 1753-1760
-
-
Donghi, R.1
Longoni, A.2
Pilotti, S.3
Michieli, P.4
Della Porta, G.5
Pierotti, M.A.6
-
6
-
-
0027455042
-
High prevalence of mutations of the p53 gene in poorly differentiated human thyroid carcinomas
-
J. A. Fagin, K. Matsuo, A. Karmakar, S. H. Tang, and H. P. Koeffler, "High prevalence of mutations of the p53 gene in poorly differentiated human thyroid carcinomas," The Journal of Clinical Investigation, vol. 91, no. 1, pp. 179-184, 1993.
-
(1993)
The Journal of Clinical Investigation
, vol.91
, Issue.1
, pp. 179-184
-
-
Fagin, J.A.1
Matsuo, K.2
Karmakar, A.3
Tang, S.H.4
Koeffler, H.P.5
-
7
-
-
84883711485
-
Frequent somatic TERT promoter mutations in thyroid cancer: Higher prevalence in advanced forms of the disease
-
I. Landa, I. Ganly, TA. Chan et al., "Frequent somatic TERT promoter mutations in thyroid cancer: higher prevalence in advanced forms of the disease," Journal of Clinical Endocrinology and Metabolism, vol. 98, pp. E1562-E1566, 2013.
-
(2013)
Journal of Clinical Endocrinology and Metabolism
, vol.98
, pp. E1562-E1566
-
-
Landa, I.1
Ganly, I.2
Chan, T.A.3
-
8
-
-
84882805198
-
Highly prevalent TERT promoter mutations in aggressive thyroid cancers
-
X. Liu, J. Bishop, Y. Shan et al., "Highly prevalent TERT promoter mutations in aggressive thyroid cancers," Endocrine-Related Cancer, vol. 20, no. 4, pp. 603-610, 2013.
-
(2013)
Endocrine-Related Cancer
, vol.20
, Issue.4
, pp. 603-610
-
-
Liu, X.1
Bishop, J.2
Shan, Y.3
-
9
-
-
66349098309
-
Mutational profile of advanced primary and metastatic radioactive iodine-refractory thyroid cancers reveals distinct pathogenetic roles for BRAF, PIK3CA, and AKT1
-
J. C. Ricarte-Filho, M. Ryder, D. A. Chitale et al., "Mutational profile of advanced primary and metastatic radioactive iodine-refractory thyroid cancers reveals distinct pathogenetic roles for BRAF, PIK3CA, and AKT1," Cancer Research, vol. 69, no. 11, pp. 4885-4893, 2009.
-
(2009)
Cancer Research
, vol.69
, Issue.11
, pp. 4885-4893
-
-
Ricarte-Filho, J.C.1
Ryder, M.2
Chitale, D.A.3
-
10
-
-
65549128212
-
Anaplastic thyroid cancer: Molecular pathogenesis and emerging therapies
-
R. C. Smallridge, L. A. Marlow, and J. A. Copland, "Anaplastic thyroid cancer: molecular pathogenesis and emerging therapies," Endocrine-Related Cancer, vol. 16, no. 1, pp. 17-44, 2009.
-
(2009)
Endocrine-Related Cancer
, vol.16
, Issue.1
, pp. 17-44
-
-
Smallridge, R.C.1
Marlow, L.A.2
Copland, J.A.3
-
11
-
-
10744222003
-
BRAF mutations in thyroid tumors are restricted to papillary carcinomas and anaplastic or poorly differentiated carcinomas arising from papillary carcinomas
-
M. N. Nikiforova, E. T. Kimura, M. Gandhi et al., "BRAF mutations in thyroid tumors are restricted to papillary carcinomas and anaplastic or poorly differentiated carcinomas arising from papillary carcinomas," Journal of Clinical Endocrinology and Metabolism, vol. 88, no. 11, pp. 5399-5404, 2003.
-
(2003)
Journal of Clinical Endocrinology and Metabolism
, vol.88
, Issue.11
, pp. 5399-5404
-
-
Nikiforova, M.N.1
Kimura, E.T.2
Gandhi, M.3
-
12
-
-
0033561515
-
Frequent mutation and nuclear local-ization of β-catenin in anaplastic thyroid carcinoma,"
-
G. Garcia-Rostan, G. Tallini, A. Herrero, T. G. D'Aquila, M. L. Carcangiu, and D. L. Rimm, "Frequent mutation and nuclear local-ization of β-catenin in anaplastic thyroid carcinoma," Cancer Research, vol. 59, no. 8, pp. 1811-1815, 1999.
-
(1999)
Cancer Research
, vol.59
, Issue.8
, pp. 1811-1815
-
-
Garcia-Rostan, G.1
Tallini, G.2
Herrero, A.3
D'Aquila, T.G.4
Carcangiu, M.L.5
Rimm, D.L.6
-
13
-
-
20144372793
-
Targeted expression of BRAFV600E in thyroid cells of transgenic mice results in papillary thyroid cancers that undergo dedifferentiation
-
J. A. Knauf, X. Ma, E. P. Smith et al., "Targeted expression of BRAFV600E in thyroid cells of transgenic mice results in papillary thyroid cancers that undergo dedifferentiation," Cancer Research, vol. 65, no. 10, pp. 4238-4245, 2005.
-
(2005)
Cancer Research
, vol.65
, Issue.10
, pp. 4238-4245
-
-
Knauf, J.A.1
Ma, X.2
Smith, E.P.3
-
14
-
-
79960381628
-
Progression of BRAF-induced thyroid cancer is associated with epithelial-mesenchymal transition requiring concomitant MAP kinase and TGFB signaling
-
J. A. Knauf, M. A. Sartor, M. Medvedovic et al., "Progression of BRAF-induced thyroid cancer is associated with epithelial-mesenchymal transition requiring concomitant MAP kinase and TGFB signaling," Oncogene, vol. 30, no. 28, pp. 3153-3162, 2011.
-
(2011)
Oncogene
, vol.30
, Issue.28
, pp. 3153-3162
-
-
Knauf, J.A.1
Sartor, M.A.2
Medvedovic, M.3
-
15
-
-
84898411721
-
p53 constrains progression to anaplastic thyroid carcinoma in a Braf-mutant mouse model of papillary thyroid cancer
-
D. G. McFadden, A. Vernon, P. M. Santiago et al., "p53 constrains progression to anaplastic thyroid carcinoma in a Braf-mutant mouse model of papillary thyroid cancer," Proceedings of the National Academy of Sciences of the United States of America, vol. 111, no. 16, pp. E1600-E1609, 2014.
-
(2014)
Proceedings of the National Academy of Sciences of the United States of America
, vol.111
, Issue.16
, pp. E1600-E1609
-
-
McFadden, D.G.1
Vernon, A.2
Santiago, P.M.3
-
16
-
-
84865273469
-
Thyrocyte-specific inactivation of p53 and Pten results in anaplastic thyroid carcinomas faithfully recapitulating human tumors
-
V. G. Antico Arciuch, M. A. Russo, M. Dima et al., "Thyrocyte-specific inactivation of p53 and Pten results in anaplastic thyroid carcinomas faithfully recapitulating human tumors," Oncotarget, vol. 2, no. 12, pp. 1109-1126, 2011.
-
(2011)
Oncotarget
, vol.2
, Issue.12
, pp. 1109-1126
-
-
Antico Arciuch, V.G.1
Russo, M.A.2
Dima, M.3
-
17
-
-
30044436911
-
The role of microRNA genes in papillary thyroid carcinoma
-
H. He, K. Jazdzewski, W. Li et al., "The role of microRNA genes in papillary thyroid carcinoma," Proceedings of the National Academy of Sciences of the United States of America, vol. 102, no. 52, pp. 19075-19080, 2005.
-
(2005)
Proceedings of the National Academy of Sciences of the United States of America
, vol.102
, Issue.52
, pp. 19075-19080
-
-
He, H.1
Jazdzewski, K.2
Li, W.3
-
18
-
-
43049180764
-
MicroRNA expression profiling of thyroid tumors: Biological significance and diagnostic utility
-
M.N.Nikiforova, G. C. Tseng, D. Steward, D. Diorio, and Y. E. Nikiforov, "MicroRNA expression profiling of thyroid tumors: biological significance and diagnostic utility," Journal of Clinical Endocrinology and Metabolism, vol. 93, no. 5, pp. 1600-1608, 2008.
-
(2008)
Journal of Clinical Endocrinology and Metabolism
, vol.93
, Issue.5
, pp. 1600-1608
-
-
Nikiforova, M.N.1
Tseng, G.C.2
Steward, D.3
Diorio, D.4
Nikiforov, Y.E.5
-
19
-
-
84872082092
-
Inverse correlation of miRNA and cell cycle-associated genes suggests influence of miRNA on benign thyroid nodule tumorigenesis
-
C. Ferraz, S. Lorenz, B. Wojtas, S. R. Bornstein, R. Paschke, and M. Eszlinger, "Inverse correlation of miRNA and cell cycle-associated genes suggests influence of miRNA on benign thyroid nodule tumorigenesis," Journal of Clinical Endocrinology and Metabolism, vol. 98, E8, no. 1, p. E16, 2013.
-
(2013)
Journal of Clinical Endocrinology and Metabolism
, vol.98
, Issue.1
, pp. E8+E16
-
-
Ferraz, C.1
Lorenz, S.2
Wojtas, B.3
Bornstein, S.R.4
Paschke, R.5
Eszlinger, M.6
-
20
-
-
36749001614
-
Specific microRNAs are downregulated in human thyroid anaplastic carcinomas
-
R. Visone, P. Pallante, A. Vecchione et al., "Specific microRNAs are downregulated in human thyroid anaplastic carcinomas," Oncogene, vol. 26, no. 54, pp. 7590-7595, 2007.
-
(2007)
Oncogene
, vol.26
, Issue.54
, pp. 7590-7595
-
-
Visone, R.1
Pallante, P.2
Vecchione, A.3
-
21
-
-
77954956544
-
Downregulation of microRNAs directs the EMT and invasive potential of anaplastic thyroid carcinomas
-
J. Braun, C. Hoang-Vu, H. Dralle, and S. Hüttelmaier, "Downregulation of microRNAs directs the EMT and invasive potential of anaplastic thyroid carcinomas," Oncogene, vol. 29, no. 29, pp. 4237-4244, 2010.
-
(2010)
Oncogene
, vol.29
, Issue.29
, pp. 4237-4244
-
-
Braun, J.1
Hoang-Vu, C.2
Dralle, H.3
Hüttelmaier, S.4
-
22
-
-
79952283482
-
p53 regulates epithelial-mesenchymal transition and stem cell properties through modulating miRNAs
-
C. J. Chang, C. H. Chao,W. Xia et al., "p53 regulates epithelial-mesenchymal transition and stem cell properties through modulating miRNAs," Nature Cell Biology, vol. 13, pp. 317-323, 2011.
-
(2011)
Nature Cell Biology
, vol.13
, pp. 317-323
-
-
Chang, C.J.1
Chao, C.H.2
Xia, W.3
-
23
-
-
84866423871
-
MicroRNAs in the p53 network: Micromanagement of tumour suppression
-
H. Hermeking, "MicroRNAs in the p53 network: micromanagement of tumour suppression," Nature Reviews Cancer, vol. 12, no. 9, pp. 613-626, 2012.
-
(2012)
Nature Reviews Cancer
, vol.12
, Issue.9
, pp. 613-626
-
-
Hermeking, H.1
-
24
-
-
19944426526
-
Epidermal growth factor receptor (EGFR) is overexpressed in anaplastic thyroid cancer, and the EGFR inhibitor gefitinib inhibits the growth of anaplastic thyroid cancer
-
B. A. Schiff, A. B. McMurphy, S. A. Jasser et al., "Epidermal growth factor receptor (EGFR) is overexpressed in anaplastic thyroid cancer, and the EGFR inhibitor gefitinib inhibits the growth of anaplastic thyroid cancer," Clinical Cancer Research, vol. 10, no. 24, pp. 8594-8602, 2004.
-
(2004)
Clinical Cancer Research
, vol.10
, Issue.24
, pp. 8594-8602
-
-
Schiff, B.A.1
McMurphy, A.B.2
Jasser, S.A.3
-
25
-
-
84866507849
-
The miR-200 family regulates the epithelial-mesenchymal transition induced by EGF/EGFR in anaplastic thyroid cancer cells
-
Z. Zhang, Z. Liu, W. Ren, X. Ye, and Y. Zhang, "The miR-200 family regulates the epithelial-mesenchymal transition induced by EGF/EGFR in anaplastic thyroid cancer cells," International Journal of Molecular Medicine, vol. 30, no. 4, pp. 856-862, 2012.
-
(2012)
International Journal of Molecular Medicine
, vol.30
, Issue.4
, pp. 856-862
-
-
Zhang, Z.1
Liu, Z.2
Ren, W.3
Ye, X.4
Zhang, Y.5
-
26
-
-
67449087324
-
Identification of novel microRNA targets based on microRNA signatures in bladder cancer
-
T. Ichimi, H. Enokida, Y. Okuno et al., "Identification of novel microRNA targets based on microRNA signatures in bladder cancer," International Journal of Cancer, vol. 125, no. 2, pp. 345-352, 2009.
-
(2009)
International Journal of Cancer
, vol.125
, Issue.2
, pp. 345-352
-
-
Ichimi, T.1
Enokida, H.2
Okuno, Y.3
-
27
-
-
84874382521
-
MicroRNA miR-30 family regulates non-attachment growth of breast cancer cells
-
M. Ouzounova, T. Vuong, P. Ancey et al., "MicroRNA miR-30 family regulates non-attachment growth of breast cancer cells," BMC Genomics, vol. 14, article 139, 2013.
-
(2013)
BMC Genomics
, vol.14
-
-
Ouzounova, M.1
Vuong, T.2
Ancey, P.3
-
28
-
-
70349134366
-
MicroRNA expression profiling of human metastatic cancers identifies cancer gene targets
-
R. Baffa, M. Fassan, S. Volinia et al., "MicroRNA expression profiling of human metastatic cancers identifies cancer gene targets," The Journal of Pathology, vol. 219, no. 2, pp. 214-221, 2009.
-
(2009)
The Journal of Pathology
, vol.219
, Issue.2
, pp. 214-221
-
-
Baffa, R.1
Fassan, M.2
Volinia, S.3
-
29
-
-
68149170082
-
Analysis of deregulated miRNAs is helpful to distinguish poorly differentiated thyroid carcinoma from papillary thyroid carcinoma
-
S. Schwertheim, S. Sheu, K. Worm, F. Grabellus, and K. W. Schmid, "Analysis of deregulated miRNAs is helpful to distinguish poorly differentiated thyroid carcinoma from papillary thyroid carcinoma," Hormone and Metabolic Research, vol. 41, no. 6, pp. 475-481, 2009.
-
(2009)
Hormone and Metabolic Research
, vol.41
, Issue.6
, pp. 475-481
-
-
Schwertheim, S.1
Sheu, S.2
Worm, K.3
Grabellus, F.4
Schmid, K.W.5
-
30
-
-
84860758213
-
Down-regulation of the miR-25 and miR-30d contributes to the development of anaplastic thyroid carcinoma targeting the polycomb protein EZH2
-
F. Esposito, M. Tornincasa, P. Pallante et al., "Down-regulation of the miR-25 and miR-30d contributes to the development of anaplastic thyroid carcinoma targeting the polycomb protein EZH2," Journal of Clinical Endocrinology and Metabolism, vol. 97, no. 5, pp. E710-E718, 2012.
-
(2012)
Journal of Clinical Endocrinology and Metabolism
, vol.97
, Issue.5
, pp. E710-E718
-
-
Esposito, F.1
Tornincasa, M.2
Pallante, P.3
-
31
-
-
79953862870
-
Enhancer of zeste homolog 2 overexpression has a role in the development of anaplastic thyroid carcinomas
-
E. Borbone, G. Troncone, A. Ferraro et al., "Enhancer of zeste homolog 2 overexpression has a role in the development of anaplastic thyroid carcinomas," Journal of Clinical Endocrinology and Metabolism, vol. 96, no. 4, pp. 1029-1038, 2011.
-
(2011)
Journal of Clinical Endocrinology and Metabolism
, vol.96
, Issue.4
, pp. 1029-1038
-
-
Borbone, E.1
Troncone, G.2
Ferraro, A.3
-
32
-
-
69449097865
-
Regulation of autophagy by a beclin 1-targeted microRNA, miR-30a, in cancer cells
-
H. Zhu, H. Wu, X. Liu et al., "Regulation of autophagy by a beclin 1-targeted microRNA, miR-30a, in cancer cells," Autophagy, vol. 5, no. 6, pp. 816-823, 2009.
-
(2009)
Autophagy
, vol.5
, Issue.6
, pp. 816-823
-
-
Zhu, H.1
Wu, H.2
Liu, X.3
-
33
-
-
84893808368
-
Regulation of autophagy by miR-30d impacts sensitivity of anaplastic thyroid carcinoma to cisplatin
-
Y. Zhang, W. Q. Yang, H. Zhu et al., "Regulation of autophagy by miR-30d impacts sensitivity of anaplastic thyroid carcinoma to cisplatin," Biochemical Pharmacology, vol. 87, pp. 562-570, 2014.
-
(2014)
Biochemical Pharmacology
, vol.87
, pp. 562-570
-
-
Zhang, Y.1
Yang, W.Q.2
Zhu, H.3
-
34
-
-
84872731006
-
MicroRNA role in thyroid cancer development
-
F. Marini, E. Luzi, and M. L. Brandi, "MicroRNA role in thyroid cancer development," Journal of Thyroid Research, vol. 2011, Article ID 407123, 12 pages, 2011.
-
(2011)
Journal of Thyroid Research
, vol.2011
-
-
Marini, F.1
Luzi, E.2
Brandi, M.L.3
-
35
-
-
84892949137
-
Let-7 and cancer
-
N. Dahiya, Ed., Nova Science Publishers, New York, NY, USA
-
C. S. Fuziwara, M. V. Geraldo, and E. T. kimura, "Let-7 and cancer," in MicroRNA Let-7: Role in Human Diseases and Drug Discovery, N. Dahiya, Ed., pp. 109-124, Nova Science Publishers, New York, NY, USA, 2012.
-
(2012)
MicroRNA Let-7: Role in Human Diseases and Drug Discovery
, pp. 109-124
-
-
Fuziwara, C.S.1
Geraldo, M.V.2
Kimura, E.T.3
-
36
-
-
2542626605
-
Reduced expression of the let-7 microRNAs in human lung cancers in association with shortened postoperative survival
-
J. Takamizawa, H. Konishi, K. Yanagisawa et al., "Reduced expression of the let-7 microRNAs in human lung cancers in association with shortened postoperative survival," Cancer Research, vol. 64, no. 11, pp. 3753-3756, 2004.
-
(2004)
Cancer Research
, vol.64
, Issue.11
, pp. 3753-3756
-
-
Takamizawa, J.1
Konishi, H.2
Yanagisawa, K.3
-
37
-
-
33745077330
-
MicroRNA deregulation in human thyroid papillary carcinomas
-
P. Pallante, R. Visone, M. Ferracin et al., "MicroRNA deregulation in human thyroid papillary carcinomas," Endocrine-Related Cancer, vol. 13, no. 2, pp. 497-508, 2006.
-
(2006)
Endocrine-Related Cancer
, vol.13
, Issue.2
, pp. 497-508
-
-
Pallante, P.1
Visone, R.2
Ferracin, M.3
-
38
-
-
84881510818
-
In-depth characterization of the MicroRNA transcriptome in normal thyroid and papillary thyroid carcinoma
-
M. Swierniak, A. Wojcicka, M. Czetwertynska et al., "In-depth characterization of the MicroRNA transcriptome in normal thyroid and papillary thyroid carcinoma," Journal of Clinical Endocrinology and Metabolism, vol. 98, no. 8, pp. E1401-E1409, 2013.
-
(2013)
Journal of Clinical Endocrinology and Metabolism
, vol.98
, Issue.8
, pp. E1401-E1409
-
-
Swierniak, M.1
Wojcicka, A.2
Czetwertynska, M.3
-
39
-
-
84868628472
-
Let-7a down regulation plays a role in thyroid neoplasias of follicular histotype affecting cell adhesion and migration through its ability to target the FXYD5 (Dysadherin) gene
-
M. Colamaio, G. Calì, D. Sarnataro et al., "Let-7a down regulation plays a role in thyroid neoplasias of follicular histotype affecting cell adhesion and migration through its ability to target the FXYD5 (Dysadherin) gene," Journal of Clinical Endocrinology and Metabolism, vol. 97, no. 11, pp. E2168-E2178, 2012.
-
(2012)
Journal of Clinical Endocrinology and Metabolism
, vol.97
, Issue.11
, pp. E2168-E2178
-
-
Colamaio, M.1
Calì, G.2
Sarnataro, D.3
-
40
-
-
77950841115
-
Effects of let-7 microRNA on cell growth and differentiation of papillary thyroid cancer
-
J. C. M. Ricarte-Filho, C. S. Fuziwara, A. S. Yamashita, E. Rezende, M. J. da-Silva, and E. T. Kimura, "Effects of let-7 microRNA on cell growth and differentiation of papillary thyroid cancer," Translational Oncology, vol. 2, no. 4, pp. 236-241, 2009.
-
(2009)
Translational Oncology
, vol.2
, Issue.4
, pp. 236-241
-
-
Ricarte-Filho, J.C.M.1
Fuziwara, C.S.2
Yamashita, A.S.3
Rezende, E.4
Da-Silva, M.J.5
Kimura, E.T.6
-
41
-
-
84880551342
-
Let-7c governs the acquisition of chemo- or radioresistance and epithelial-to-mesenchymal transition phenotypes in docetaxel-resistant lung adenocarcinoma
-
S. Y. Cui, J. Y. Huang, Y. T. Chen et al., "Let-7c governs the acquisition of chemo- or radioresistance and epithelial-to-mesenchymal transition phenotypes in docetaxel-resistant lung adenocarcinoma," Molecular Cancer Research, vol. 11, no. 7, pp. 699-713, 2013.
-
(2013)
Molecular Cancer Research
, vol.11
, Issue.7
, pp. 699-713
-
-
Cui, S.Y.1
Huang, J.Y.2
Chen, Y.T.3
-
42
-
-
84896766487
-
High iodine blocks a Notch/miR-19 loop activated by the BRAFV600E oncoprotein and restores the response to TGFbeta in thyroid follicular cells
-
C. S. Fuziwara and E. T. Kimura, "High iodine blocks a Notch/miR-19 loop activated by the BRAFV600E oncoprotein and restores the response to TGFbeta in thyroid follicular cells," Thyroid, vol. 24, no. 3, pp. 453-462, 2013.
-
(2013)
Thyroid
, vol.24
, Issue.3
, pp. 453-462
-
-
Fuziwara, C.S.1
Kimura, E.T.2
-
43
-
-
33645964942
-
- targeting to the membrane
-
- targeting to the membrane," Endocrine-Related Cancer, vol. 13, no. 1, pp. 257-269, 2006.
-
(2006)
Endocrine-Related Cancer
, vol.13
, Issue.1
, pp. 257-269
-
-
Riesco-Eizaguirre, G.1
Gutiérrez-Martínez, P.2
García-Cabezas, M.A.3
Nistal, M.4
Santisteban, P.5
-
44
-
-
28744442816
-
BRAF mutation predicts a poorer clinical prognosis for papillary thyroid cancer
-
M. Xing, W. H. Westra, R. P. Tufano et al., "BRAF mutation predicts a poorer clinical prognosis for papillary thyroid cancer," Journal of Clinical Endocrinology and Metabolism, vol. 90, no. 12, pp. 6373-6379, 2005.
-
(2005)
Journal of Clinical Endocrinology and Metabolism
, vol.90
, Issue.12
, pp. 6373-6379
-
-
Xing, M.1
Westra, W.H.2
Tufano, R.P.3
-
45
-
-
43549098845
-
Oncogenic role of miR-17-92 cluster in anaplastic thyroid cancer cells
-
S. Takakura, N. Mitsutake, M. Nakashima et al., "Oncogenic role of miR-17-92 cluster in anaplastic thyroid cancer cells," Cancer Science, vol. 99, no. 6, pp. 1147-1154, 2008.
-
(2008)
Cancer Science
, vol.99
, Issue.6
, pp. 1147-1154
-
-
Takakura, S.1
Mitsutake, N.2
Nakashima, M.3
-
46
-
-
33144490646
-
A microRNA expression signature of human solid tumors defines cancer gene targets
-
S. Volinia, G. A. Calin, C. Liu et al., "A microRNA expression signature of human solid tumors defines cancer gene targets," Proceedings of the National Academy of Sciences of the United States of America, vol. 103, no. 7, pp. 2257-2261, 2006.
-
(2006)
Proceedings of the National Academy of Sciences of the United States of America
, vol.103
, Issue.7
, pp. 2257-2261
-
-
Volinia, S.1
Calin, G.A.2
Liu, C.3
-
47
-
-
27544495514
-
A polycistronic MicroRNA cluster, miR-17-92, is overexpressed in human lung cancers and enhances cell proliferation
-
Y. Hayashita, H. Osada, Y. Tatematsu et al., "A polycistronic MicroRNA cluster, miR-17-92, is overexpressed in human lung cancers and enhances cell proliferation," Cancer Research, vol. 65, no. 21, pp. 9628-9632, 2005.
-
(2005)
Cancer Research
, vol.65
, Issue.21
, pp. 9628-9632
-
-
Hayashita, Y.1
Osada, H.2
Tatematsu, Y.3
-
48
-
-
77749233761
-
Nuclear factor-κb contributes to anaplastic thyroid carcinomas through up-regulation of miR-146a
-
F. Pacifico, E. Crescenzi, S. Mellone et al., "Nuclear factor-κb contributes to anaplastic thyroid carcinomas through up-regulation of miR-146a," Journal of Clinical Endocrinology and Metabolism, vol. 95, no. 3, pp. 1421-1430, 2010.
-
(2010)
Journal of Clinical Endocrinology and Metabolism
, vol.95
, Issue.3
, pp. 1421-1430
-
-
Pacifico, F.1
Crescenzi, E.2
Mellone, S.3
-
49
-
-
19944426112
-
Oncogenic and anti-apoptotic activity of NF-κB in human thyroid carcinomas
-
F. Pacifico, C. Mauro, C. Barone et al., "Oncogenic and anti-apoptotic activity of NF-κB in human thyroid carcinomas," The Journal of Biological Chemistry, vol. 279, no. 52, pp. 54610-54619, 2004.
-
(2004)
The Journal of Biological Chemistry
, vol.279
, Issue.52
, pp. 54610-54619
-
-
Pacifico, F.1
Mauro, C.2
Barone, C.3
-
50
-
-
33847298591
-
Gene expression and functional evidence of epithelial-to-mesenchymal transition in papillary thyroid carcinoma invasion
-
V. Vasko, A. V. Espinosa, W. Scouten et al., "Gene expression and functional evidence of epithelial-to-mesenchymal transition in papillary thyroid carcinoma invasion," Proceedings of the National Academy of Sciences of the United States of America, vol. 104, no. 8, pp. 2803-2808, 2007.
-
(2007)
Proceedings of the National Academy of Sciences of the United States of America
, vol.104
, Issue.8
, pp. 2803-2808
-
-
Vasko, V.1
Espinosa, A.V.2
Scouten, W.3
-
51
-
-
33751549248
-
BRAFV600E promotes invasiveness of thyroid cancer cells through nuclear factor κB activation
-
I. Palona, H. Namba, N. Mitsutake et al., "BRAFV600E promotes invasiveness of thyroid cancer cells through nuclear factor κB activation," Endocrinology, vol. 147, no. 12, pp. 5699-5707, 2006.
-
(2006)
Endocrinology
, vol.147
, Issue.12
, pp. 5699-5707
-
-
Palona, I.1
Namba, H.2
Mitsutake, N.3
-
52
-
-
84859746790
-
MicroRNA miR-146b-5p regulates signal transduction of TGF-B by repressing SMAD4 in thyroid cancer
-
M. V. Geraldo, A. S. Yamashita, and E. T. Kimura, "MicroRNA miR-146b-5p regulates signal transduction of TGF-B by repressing SMAD4 in thyroid cancer," Oncogene, vol. 31, no. 15, pp. 1910-1922, 2012.
-
(2012)
Oncogene
, vol.31
, Issue.15
, pp. 1910-1922
-
-
Geraldo, M.V.1
Yamashita, A.S.2
Kimura, E.T.3
-
53
-
-
84873675700
-
Prognostic implications of miR-146b expression and its functional role in papillary thyroid carcinoma
-
C. Chou, K. D. Yang, F. Chou et al., "Prognostic implications of miR-146b expression and its functional role in papillary thyroid carcinoma," The Journal of Clinical Endocrinology and Metabolism, vol. 98, no. 2, pp. E196-E205, 2013.
-
(2013)
The Journal of Clinical Endocrinology and Metabolism
, vol.98
, Issue.2
, pp. E196-E205
-
-
Chou, C.1
Yang, K.D.2
Chou, F.3
-
54
-
-
84889881151
-
MicroRNA-222 and microRNA-146b are tissue and circulating biomarkers of recurrent papillary thyroid cancer
-
J. C. Lee, J. T. Zhao, R. J. Clifton-Bligh et al., "MicroRNA-222 and microRNA-146b are tissue and circulating biomarkers of recurrent papillary thyroid cancer," Cancer, vol. 119, no. 24, pp. 4358-4365, 2013.
-
(2013)
Cancer
, vol.119
, Issue.24
, pp. 4358-4365
-
-
Lee, J.C.1
Zhao, J.T.2
Clifton-Bligh, R.J.3
-
55
-
-
38949168082
-
Downregulation of miR-138 is associated with overexpression of human telomerase reverse transcriptase protein in human anaplastic thyroid carcinoma cell lines
-
S. Mitomo, C. Maesawa, S. Ogasawara et al., "Downregulation of miR-138 is associated with overexpression of human telomerase reverse transcriptase protein in human anaplastic thyroid carcinoma cell lines," Cancer Science, vol. 99, no. 2, pp. 280-286, 2008.
-
(2008)
Cancer Science
, vol.99
, Issue.2
, pp. 280-286
-
-
Mitomo, S.1
Maesawa, C.2
Ogasawara, S.3
-
56
-
-
77952386365
-
V600E mutation
-
V600E mutation," Thyroid, vol. 20, no. 5, pp. 489-494, 2010.
-
(2010)
Thyroid
, vol.20
, Issue.5
, pp. 489-494
-
-
Chou, C.K.1
Chen, R.F.2
Chou, F.F.3
-
57
-
-
84875719309
-
Association between the expression of four upregulated miRNAs and extrathyroidal invasion in papillary thyroid carcinoma
-
Z. Wang, H. Zhang, L. He et al., "Association between the expression of four upregulated miRNAs and extrathyroidal invasion in papillary thyroid carcinoma," OncoTargets and Therapy, vol. 6, pp. 281-287, 2013.
-
(2013)
OncoTargets and Therapy
, vol.6
, pp. 281-287
-
-
Wang, Z.1
Zhang, H.2
He, L.3
-
58
-
-
84889881151
-
MicroRNA-222 and MicroRNA-146b are tissue and circulating biomarkers of recurrent papillary thyroid cancer
-
J. C. Lee, J. T. Zhao, R. J. Clifton-Bligh et al., "MicroRNA-222 and MicroRNA-146b are tissue and circulating biomarkers of recurrent papillary thyroid cancer," Cancer, vol. 119, no. 24, pp. 4358-4365, 2013.
-
(2013)
Cancer
, vol.119
, Issue.24
, pp. 4358-4365
-
-
Lee, J.C.1
Zhao, J.T.2
Clifton-Bligh, R.J.3
-
59
-
-
84876566718
-
The miR-221/222 cluster, miR-10b and miR-92a are highly upregulated in metastatic minimally invasive follicular thyroid carcinoma
-
T. Jikuzono, M. Kawamoto, H. Yoshitake et al., "The miR-221/222 cluster, miR-10b and miR-92a are highly upregulated in metastatic minimally invasive follicular thyroid carcinoma," International Journal of Oncology, vol. 42, no. 6, pp. 1858-1868, 2013.
-
(2013)
International Journal of Oncology
, vol.42
, Issue.6
, pp. 1858-1868
-
-
Jikuzono, T.1
Kawamoto, M.2
Yoshitake, H.3
-
60
-
-
84890980853
-
MicroRNA-221 promotes colorectal cancer cell invasion and metastasis by targeting RECK
-
J. Qin and M. Luo, "MicroRNA-221 promotes colorectal cancer cell invasion and metastasis by targeting RECK," FEBS letters, vol. 588, no. 1, pp. 99-104, 2014.
-
(2014)
FEBS Letters
, vol.588
, Issue.1
, pp. 99-104
-
-
Qin, J.1
Luo, M.2
-
61
-
-
35948975794
-
MicroRNAs (miR)-221 and miR-222, both overexpressed in human thyroid papillary carcinomas, regulate p27Kip1 protein levels and cell cycle
-
R. Visone, L. Russo, P. Pallante et al., "MicroRNAs (miR)-221 and miR-222, both overexpressed in human thyroid papillary carcinomas, regulate p27Kip1 protein levels and cell cycle," Endocrine-Related Cancer, vol. 14, no. 3, pp. 791-798, 2007.
-
(2007)
Endocrine-Related Cancer
, vol.14
, Issue.3
, pp. 791-798
-
-
Visone, R.1
Russo, L.2
Pallante, P.3
-
62
-
-
84907400323
-
Modulation of deregulated microRNAs for target therapy in thyroid cancer
-
F. H. Sarkar, Ed., Springer, Cham, Switzerland, 1st edition
-
C. S. Fuziwara and E. T. Kimura, "Modulation of deregulated microRNAs for target therapy in thyroid cancer," in MicroRNA Targeted Cancer Therapy, F. H. Sarkar, Ed., pp. 219-237, Springer, Cham, Switzerland, 1st edition, 2014.
-
(2014)
MicroRNA Targeted Cancer Therapy
, pp. 219-237
-
-
Fuziwara, C.S.1
Kimura, E.T.2
-
63
-
-
79751473114
-
The microRNA miR-34a inhibits prostate cancer stem cells and metastasis by directly repressing CD44
-
C. Liu, K. Kelnar, B. Liu et al., "The microRNA miR-34a inhibits prostate cancer stem cells and metastasis by directly repressing CD44," Nature Medicine, vol. 17, no. 2, pp. 211-215, 2011.
-
(2011)
Nature Medicine
, vol.17
, Issue.2
, pp. 211-215
-
-
Liu, C.1
Kelnar, K.2
Liu, B.3
-
64
-
-
74149083873
-
Systemic delivery of synthetic microRNA-16 inhibits the growth of metastatic prostate tumors via downregulation of multiple cell-cycle genes
-
F. Takeshita, L. Patrawala, M. Osaki et al., "Systemic delivery of synthetic microRNA-16 inhibits the growth of metastatic prostate tumors via downregulation of multiple cell-cycle genes," Molecular Therapy, vol. 18, no. 1, pp. 181-187, 2010.
-
(2010)
Molecular Therapy
, vol.18
, Issue.1
, pp. 181-187
-
-
Takeshita, F.1
Patrawala, L.2
Osaki, M.3
-
65
-
-
79957900919
-
Systemic delivery of tumor suppressor microRNA mimics using a neutral lipid emulsion inhibits lung tumors in mice
-
P. Trang, J. F. Wiggins, C. L. Daige et al., "Systemic delivery of tumor suppressor microRNA mimics using a neutral lipid emulsion inhibits lung tumors in mice," Molecular Therapy, vol. 19, no. 6, pp. 1116-1122, 2011.
-
(2011)
Molecular Therapy
, vol.19
, Issue.6
, pp. 1116-1122
-
-
Trang, P.1
Wiggins, J.F.2
Daige, C.L.3
-
66
-
-
84877258007
-
Treatment of HCV infection by targeting microRNA
-
H. L. A. Janssen, H. W. Reesink, E. J. Lawitz et al., "Treatment of HCV infection by targeting microRNA," The New England Journal of Medicine, vol. 368, no. 18, pp. 1685-1694, 2013.
-
(2013)
The New England Journal of Medicine
, vol.368
, Issue.18
, pp. 1685-1694
-
-
Janssen, H.L.A.1
Reesink, H.W.2
Lawitz, E.J.3
-
67
-
-
84862176128
-
TarBase 6.0: Capturing the exponential growth of miRNA targets with experimental support
-
T. Vergoulis, I. S. Vlachos, P. Alexiou et al., "TarBase 6.0: capturing the exponential growth of miRNA targets with experimental support," Nucleic Acids Research, vol. 40, no. 1, pp.D222-D229, 2012.
-
(2012)
Nucleic Acids Research
, vol.40
, Issue.1
, pp. D222-D229
-
-
Vergoulis, T.1
Vlachos, I.S.2
Alexiou, P.3
-
68
-
-
20044395613
-
RAS is regulated by the let-7 microRNA family
-
S. M. Johnson, H. Grosshans, J. Shingara et al., "RAS is regulated by the let-7 microRNA family," Cell, vol. 120, no. 5, pp. 635-647, 2005.
-
(2005)
Cell
, vol.120
, Issue.5
, pp. 635-647
-
-
Johnson, S.M.1
Grosshans, H.2
Shingara, J.3
-
69
-
-
84872711759
-
MicroRNA-125b inhibits cell migration and invasion by targeting matrix metallopeptidase 13 in bladder cancer
-
D. Wu, J. Ding, L. Wang et al., "MicroRNA-125b inhibits cell migration and invasion by targeting matrix metallopeptidase 13 in bladder cancer," Oncology Letters, vol. 5, no. 3, pp. 829-834, 2013.
-
(2013)
Oncology Letters
, vol.5
, Issue.3
, pp. 829-834
-
-
Wu, D.1
Ding, J.2
Wang, L.3
-
70
-
-
79952291503
-
Thyroid hormone receptor β (THRB) is a major target gene for microRNAs deregulated in papillary thyroid carcinoma (PTC)
-
K. Jazdzewski, J. Boguslawska, J. Jendrzejewski et al., "Thyroid hormone receptor β (THRB) is a major target gene for microRNAs deregulated in papillary thyroid carcinoma (PTC)," Journal of Clinical Endocrinology and Metabolism, vol. 96, no. 3, pp. E546-E553, 2011.
-
(2011)
Journal of Clinical Endocrinology and Metabolism
, vol.96
, Issue.3
, pp. E546-E553
-
-
Jazdzewski, K.1
Boguslawska, J.2
Jendrzejewski, J.3
-
71
-
-
52149102044
-
Expression of microRNA-146 suppresses NF-κB activity with reduction of metastatic potential in breast cancer cells
-
D. Bhaumik, G. K. Scott, S. Schokrpur, C. K. Patil, J. Campisi, and C. C. Benz, "Expression of microRNA-146 suppresses NF-κB activity with reduction of metastatic potential in breast cancer cells," Oncogene, vol. 27, no. 42, pp. 5643-5647, 2008.
-
(2008)
Oncogene
, vol.27
, Issue.42
, pp. 5643-5647
-
-
Bhaumik, D.1
Scott, G.K.2
Schokrpur, S.3
Patil, C.K.4
Campisi, J.5
Benz, C.C.6
|